Moderna's combined COVID and flu vaccine shows positive results

sciencealert.com

Moderna's phase 3 trial for a combined COVID and flu vaccine showed positive results with roughly 8,000 participants. The vaccine, mRNA-1083, elicited a strong immune response against COVID and three influenza strains. Safety was well-tolerated with common side effects. Combination vaccines offer advantages like cost reduction and increased vaccination uptake. The vaccine could be a crucial tool in increasing coverage against COVID and the flu, benefiting public health and the economy.


With a significance score of 3.2, this news ranks in the top 9.7% of today's 29144 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Moderna's combined COVID and flu vaccine shows positive results | News Minimalist